Source: silence-therapeutics.com

Silence Therapeutics received $2M in Grant Funding

Read full article »

Silence Therapeutics's Competitors | Silence Therapeutics's News | Silence Therapeutics's Financials

Followers on Owler

Annual Revenue

$25-100M

Employees

100-250

President & CEO

Craig Tooman

CEO Approval Rating

82/100

Silence Therapeutics is an England-based biotechnology company that develops RNA therapies for the treatment of cardiovascular, renal, metabolic and respiratory diseases.